{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T05:53:21Z","timestamp":1793858001412,"version":"4.6.1"},"reference-count":50,"publisher":"American Association for the Advancement of Science (AAAS)","issue":"196","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sci. Transl. Med."],"published-print":{"date-parts":[[2013,7,31]]},"abstract":"<jats:p>Persistent mTORC1 signaling correlates with resistance to PI3K p110\u03b1 inhibition in breast cancer, which can be overcome by inhibiting mTORC1.<\/jats:p>","DOI":"10.1126\/scitranslmed.3005747","type":"journal-article","created":{"date-parts":[[2013,7,31]],"date-time":"2013-07-31T14:10:12Z","timestamp":1375279812000},"source":"Crossref","is-referenced-by-count":257,"title":["mTORC1 Inhibition Is Required for Sensitivity to PI3K p110\u03b1 Inhibitors in\n                    <i>PIK3CA<\/i>\n                    -Mutant Breast Cancer"],"prefix":"10.1126","volume":"5","author":[{"given":"Moshe","family":"Elkabets","sequence":"first","affiliation":[{"name":"Human Oncology &amp; Pathogenesis Program and Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA."},{"name":"Massachusetts General Hospital Cancer Center, CNY 149, 13th Street, Charlestown, MA 02129, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadhna","family":"Vora","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital Cancer Center, CNY 149, 13th Street, Charlestown, MA 02129, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dejan","family":"Juric","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital Cancer Center, CNY 149, 13th Street, Charlestown, MA 02129, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Morse","sequence":"additional","affiliation":[{"name":"Human Oncology &amp; Pathogenesis Program and Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Mino-Kenudson","sequence":"additional","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taru","family":"Muranen","sequence":"additional","affiliation":[{"name":"Department of Cell Biology, Harvard Medical School, 240 Longwood Avenue, Boston, MA 02115, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Tao","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital Cancer Center, CNY 149, 13th Street, Charlestown, MA 02129, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Bosch","family":"Campos","sequence":"additional","affiliation":[{"name":"Human Oncology &amp; Pathogenesis Program and Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Rodon","sequence":"additional","affiliation":[{"name":"Experimental Therapeutics Group, Vall d\u2019Hebron Institute of Oncology, Pg Vall d\u2019Hebron, 119-129, Barcelona 08035, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasir H.","family":"Ibrahim","sequence":"additional","affiliation":[{"name":"Experimental Therapeutics Group, Vall d\u2019Hebron Institute of Oncology, Pg Vall d\u2019Hebron, 119-129, Barcelona 08035, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violeta","family":"Serra","sequence":"additional","affiliation":[{"name":"Experimental Therapeutics Group, Vall d\u2019Hebron Institute of Oncology, Pg Vall d\u2019Hebron, 119-129, Barcelona 08035, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Rodrik-Outmezguine","sequence":"additional","affiliation":[{"name":"Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saswati","family":"Hazra","sequence":"additional","affiliation":[{"name":"Prometheus Therapeutics &amp; Diagnostics, 9410 Carroll Park Drive, San Diego, CA 92121, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharat","family":"Singh","sequence":"additional","affiliation":[{"name":"Prometheus Therapeutics &amp; Diagnostics, 9410 Carroll Park Drive, San Diego, CA 92121, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Kim","sequence":"additional","affiliation":[{"name":"Prometheus Therapeutics &amp; Diagnostics, 9410 Carroll Park Drive, San Diego, CA 92121, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Quadt","sequence":"additional","affiliation":[{"name":"Novartis Pharma AG, Forum 1, Novartis Campus, CH-4056 Basel, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manway","family":"Liu","sequence":"additional","affiliation":[{"name":"Oncology Translational Medicine, Novartis Institutes for BioMedical Research, Cambridge, MA 02139, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Huang","sequence":"additional","affiliation":[{"name":"Oncology Translational Medicine, Novartis Institutes for BioMedical Research, Cambridge, MA 02139, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal","family":"Rosen","sequence":"additional","affiliation":[{"name":"Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Engelman","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital Cancer Center, CNY 149, 13th Street, Charlestown, MA 02129, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Scaltriti","sequence":"additional","affiliation":[{"name":"Human Oncology &amp; Pathogenesis Program and Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Baselga","sequence":"additional","affiliation":[{"name":"Human Oncology &amp; Pathogenesis Program and Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrg1879"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.296.5573.1655"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2664"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1902"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.25.5.1596-1607.2005"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0712169105"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0408864102"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1096502"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1186\/bcr3039"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-2612"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003065"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0905152106"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2009.06.006"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.11.6199"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.26.15587"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.36.1360"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2010.28.15_suppl.3005"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2010.28.15_suppl.2541"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2009.27.15_suppl.3500"},{"key":"e_1_3_2_21_2","article-title":"Single agent activity of PIK3CA inhibitor BYL719 in a broad cancer cell line panel.","volume":"72","author":"Huang A.","year":"2012","unstructured":"Huang A., Fritsch C., Wilson C., Reddy A., Liu M., Lehar J., Quadt C., Hofmann F., Schlegel R., Single agent activity of PIK3CA inhibitor BYL719 in a broad cancer cell line panel. Cancer Res. 72 (2012).","journal-title":"Cancer Res."},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.SABCS12-P6-10-07","article-title":"Phase I study of BYL719, an alpha-specific PI3K inhibitor, in patients with PIK3CA mutant advanced solid tumors: Preliminary efficacy and safety in patients with PIK3CA mutant ER-positive (ER+) metastatic breast cancer (MBC).","volume":"72","author":"Juric D.","year":"2012","unstructured":"Juric D., Argiles G., Burris H. A., Gonzalez-Angulo A. M., Saura C., Quadt C., Douglas M., Demanse D., De Buck S., Baselga J., Phase I study of BYL719, an alpha-specific PI3K inhibitor, in patients with PIK3CA mutant advanced solid tumors: Preliminary efficacy and safety in patients with PIK3CA mutant ER-positive (ER+) metastatic breast cancer (MBC). Cancer Res. 72 (2012).","journal-title":"Cancer Res."},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2012-CT-01","article-title":"BYL719, a next generation PI3K alpha specific inhibitor: Preliminary safety, PK, and efficacy results from the first-in-human study.","volume":"72","author":"Juric D.","year":"2012","unstructured":"Juric D., Rodon J., Gonzalez-Angulo A. M., Burris H. A., Bendell J., Berlin J. D., Middleton M. R., Bootle D., Boehm M., Schmitt A., Rouyrre N., Quadt C., Baselga J., BYL719, a next generation PI3K alpha specific inhibitor: Preliminary safety, PK, and efficacy results from the first-in-human study. Cancer Res. 72 (2012).","journal-title":"Cancer Res."},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.03.017"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M700906200"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm800295d"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200317222"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-9822(03)00506-2"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.10.026"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature11183"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature11249"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-12-0237"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3005753"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2402"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.695"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1108237108"},{"key":"e_1_3_2_37_2","unstructured":"S. Institute CONAN CGP copy number analysis; http:\/\/www.sanger.ac.uk\/research\/areas\/humangenetics\/cnv\/."},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-12-0404"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-08-0017"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-11-0446"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mds011"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2011.29.15_suppl.3020"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-2882"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.39.0708"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1109653"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-2750"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-11-0348"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI43757"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1685008"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1046-2023(03)00032-X"},{"key":"e_1_3_2_51_2","article-title":"Pathway profiling of signal transduction proteins in paired tumor and adjacent normal tissues obtained from breast cancer patients.","volume":"70","author":"Kim P. S.","year":"2010","unstructured":"Kim P. S., Von Ahsen O., Schmitz A., Schatz C., Magonova K., Lee T., Harvie G., Barham R., Leesman G., Kuller A., Lin F., Gong H., Krahn T., Singh S., Pathway profiling of signal transduction proteins in paired tumor and adjacent normal tissues obtained from breast cancer patients. Cancer Res. 70 (2010).","journal-title":"Cancer Res."}],"container-title":["Science Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.science.org\/doi\/pdf\/10.1126\/scitranslmed.3005747","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T12:43:26Z","timestamp":1705409006000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.science.org\/doi\/10.1126\/scitranslmed.3005747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,31]]},"references-count":50,"journal-issue":{"issue":"196","published-print":{"date-parts":[[2013,7,31]]}},"alternative-id":["10.1126\/scitranslmed.3005747"],"URL":"https:\/\/doi.org\/10.1126\/scitranslmed.3005747","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718056430.793482632","asserted-by":"object"}]},"ISSN":["1946-6234","1946-6242"],"issn-type":[{"value":"1946-6234","type":"print"},{"value":"1946-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,31]]}}}